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Abstract
Background: The pathogenesis of diverticular disease (DD) is thought to result from complex interactions among dietary
habits, genetic factors and coexistence of other bowel abnormalities. These conditions lead to alterations in colonic
pressure and motility, facilitating the formation of diverticula. Although electrophysiological studies on smooth muscle cells
(SMCs) have investigated colonic motor dysfunctions, scarce attention has been paid to their molecular abnormalities, and
data on SMCs in DD are lacking. Accordingly, the main purpose of this study was to evaluate the expression patterns of
molecular factors involved in the contractile functions of SMCs in the tunica muscularis of colonic specimens from patients
with DD.
Methods and Findings: By means of immunohistochemistry and image analysis, we examined the expression of Cx26 and
Cx43, which are prominent components of gap junctions in human colonic SMCs, as well as pS368-Cx43, PKCps, RhoA and
aSMA, all known to regulate the functions of gap junctions and the contractile activity of SMCs. The immunohistochemical
analysis revealed significant abnormalities in DD samples, concerning both the expression and distribution patterns of most
of the investigated molecular factors.
Conclusion: This study demonstrates, for the first time, that an altered pattern of factors involved in SMC contractility is
present at level of the tunica muscularis of DD patients. Moreover, considering that our analysis was conducted on colonic
tissues not directly affected by diverticular lesions or inflammatory reactions, it is conceivable that these molecular
alterations may precede and predispose to the formation of diverticula, rather than being mere consequences of the
disease.
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Introduction
Diverticular disease (DD) is one of the most common pathologic
conditions affecting the gastrointestinal tract in Western countries.
Its pathogenesis is likely multifactorial in nature, involving dietary
habits as well as changes in colonic pressure, motility and wall
structure associated with ageing [1]. Abnormalities of colonic
motility, including increments of the overall motor activity, as well
as abnormal responses to physiologic stimuli and retro-propaga-
tion of mass movements, might predispose to the formation of
pulsion diverticula by herniation of colonic wall [2–4].
Intestinal motility is regulated by complex interactions among
smooth muscle cells (SMCs) of the gut tunica muscularis, enteric
nerves and interstitial cells of Cajal (ICCs). Several lines of
evidence from DD patients suggest that the diverticular colon
displays substantial structural alterations of the enteric nervous
system, mainly charaterized by myenteric and submucosal oligo-
neuronal hypoganglionosis [5], a predominance of cholinergic
nerves [6], and a significant decrease in myenteric glial cells and
neuromuscular ICCs [7]. Other studies, performed in vitro on DD
colonic samples, have shown an impairment of the tachykininergic
pathway. In particular, colonic preparations, containing the
circular (CM) and longitudinal muscle (LM) with the embedded
myenteric plexus and the serosal layer, displayed a decreased
contractile response to exogenous substance P in combination with
a down-regulation of tachykininergic receptor genes [8–9]. Studies
on colonic smooth muscle tissue from patients with DD have also
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demonstrated a marked thickening of the CM layer, in concom-
itance with shortening of the taeniae, which appears to be
secondary to an abnormal elastin deposition [3]. However, studies
focused on the molecular features of SMCs in the tunica muscularis
of DD human colon are lacking.
Despite colonic SMCs are not all individually innervated, they
are able to generate coordinated patterns of motor activity, acting
as a functional syncithium. Indeed, the large number of gap
junctions, which are abundantly present along SMC plasma
membranes, allow the neurogenic electrical stimuli to spread from
activated neighbouring cells. Gap junctions are clusters of
intercellular channels, which consist of two apposing connexon
complexes. Each connexon comprises six connexin (Cx) proteins,
which allow the direct diffusion of ions and small molecules
between adjacent cells [10]. Among the Cxs, Cx43 is the most
widely expressed as well as the most represented in SMC gap
junctions, including those of the human gut [11]. The functions of
gap junctions can be regulated at different levels by a variety of
mechanisms such as: modulation of connexon densities on cell
membranes; Cx phosphorylation, which leads to modification of
channel conductance as well as Cx trafficking and degradation
[12]; protein kinase C (PKC) and RhoA activation [13–14]. As far
as the family of Rho proteins is concerned, these are known to act
as key regulators of several processes associated with changes in
actin cytoskeleton, such as cell migration, adhesion and contrac-
tion [15–16]. In particular, RhoA/ROCK and PKC/CPI-17
represent the major molecular pathways, known to be involved in
the late phase of smooth muscle contractility, including that of
gastrointestinal SMCs [17].
Based on the above considerations, the present study was aimed
at performing immunohistochemical studies on the distribution
and quantitative expression of Cx isoforms, Cx43 phosphorylated
at serine 368 (pS368-Cx43), PKC phosphorylated substrates, and
RhoA signaling in the neuromuscular compartment of colonic
samples from DD patients, by comparison with normal specimens.
In addition, the ICC distribution and density within the tunica
muscularis were studied by means of a morphometric method. Our
findings revealed significant abnormalities in DD samples,
concerning both the expression and distribution patterns of most
of the investigated molecular factors and ICC.
Materials and Methods
Ethics statement
Care was taken to perform the study in full accordance with
local ethical guidelines and recommendations by the Declaration
of Helsinki (Seoul revision, 2008). However, since this was a
retrospective study on archival material, no individual patient
identification was involved and no study-driven clinical interven-
tion was performed, no approval by ethical committee and no
informed consent were necessary. The original patients gave their
consent to have their tissue samples archived and used for scientific
purposes. All patients’ data were strictly de-identified and analyzed
anonymously.
Patients and tissue samples
The study was carried out on full-thickness archival samples of
left (descending and sigmoid) colon collected from 10 patients (6
women, 4 men; age range 33–82 years), who underwent elective
abdominal surgery for DD, after the third or fourth attack of
diverticulitis [18–19]. Care was taken to select tissue samples,
which included taeniae and displayed a microscopically normal
aspect, without leukocyte infiltrate, while samples showing
leukocyte infiltrate were avoided. Archival colonic samples from
8 subjects (3 women, 5 men; age range 42–80 years), who had
undergone elective left hemicolectomy for non obstructing colon
cancer, were used as controls. These samples, also selected from
areas including taeniae, were tumour-free and chosen at a distance
of at least 5 cm from the resection margin samples. The routinely
fixed and processed colonic samples were serially cross-sectioned
to obtain 8 mm-thick sections with SMCs of the circular layer and
myenteric ganglia cut longitudinally. Immediately before use,
slides were deparaffinized, rehydrated and processed for both
routine haematoxylin-eosin staining and immunohistochemistry.
For each selected colonic sample, at least 3 serial sections (1/18)
were examined.
Immunohistochemistry
The slides were exposed to microwaves for 15 min at 600 W in
10 mM sodium citrate for antigen retrieval, incubated with 3%
H2O2/dH2O for 15 min, and with normal goat serum (1:20,
Vector, Burlingame; CA, USA) for blocking endogenous perox-
idase and non-specific binding, respectively; thereafter, they were
incubated with primary antibodies in 0.1% BSA-PBS overnight at
4uC. Optimal working dilutions of primary antibodies, determined
empirically by means of serial dilutions, are summarized in
Table 1.
Detection was carried out by sequential treatments with
biotinylated anti-mouse/rabbit immunoglobulins (1:200, Vector),
strepavidin-peroxidase complex (Vector), 3.39-diaminobenzidine
tetrahydro-cloride (DAB, DakoCytomation) or DAB enhanced
with 10% nickel chloride (Sigma-Aldrich, St. Louis, Mo, USA) for
ICC detection. Sections were counterstained with Harris’s
haematoxylin or nuclear fast red (Fluka, Buchs, Switzerland) for
anti-c-Kit immunostaining. Detection of smooth muscle a-actin
(a-SMA) was performed using the Cell Marque detection kit (Cell
Marque, Rocklin, CA, USA) in accordance with the manufactur-
er’s instructions. Negative controls were obtained by omitting
primary antibodies or substituting them with pre-immune mouse/
rabbit serum (1:100).
To test the antibody specificity the following positive control
tissues were used as shown in Fig. 1: human colonic crypt
epithelium for Cx26 and Cx43 [11]; human myocardium for
pS368-Cx43 [12,20]; human enteric neurons for protein kinase C
phosphorylated substrates (PKCps) [21–22]; human granulocytes
for RhoA [23]; human mast cells for c-Kit [24]. All reactions were
performed in humid chambers at room temperature, unless
otherwise specified. Sections were then examined by means of a
Leica DMRB light microscope and DFC480 digital camera (Leica
Microsystem, Cambridge, UK) to capture representative photo-
micrographs and microscopic fields for quantitative evaluations.
Quantitative analysis of immunolabelled Cx26, Cx43,
RhoA and PKCps
Three sections were examined for each colonic sample. For
each section, 10 randomly selected microscopic fields, focused on
the tunica muscularis, were captured at 4006 magnification and
analyzed by Image Analysis System (McBiophotonics Image J) as
previously reported [24]. Briefly, 5 fields were focused on CM and
5 on LM. Each field was subjected to intensity thresholding,
depending on signal-to-noise ratio in order to highlight the
immunopositive area, which was expressed as percentage of the
total tissue area examined (percentage positive pixels [PPP]). For
each sample, the percentages of immunoreactive areas were
expressed as means 6 SD of PPP estimated on 10 fields examined
for 3 sections. For each group (controls and DD patients), the
value of immunopositive area was expressed as mean6 SD of PPP
estimated in controls or patients.
Smooth Muscle Molecules in Diverticular Disease
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Quantitative analysis of ICCs
Only c-Kit-immunostained cells with red nuclei were consid-
ered for ICC counting and density estimation, which was
performed as previously reported, with exclusion of c-Kit-positive
cells displaying the morphology and size of mast cells [24]. Briefly,
for each section, 20 randomly selected microscopic fields were
captured at 2006magnification. Ten fields were focused on CM,
and 10 on LM to count ICC-CM, and ICC-LM, respectively. ICC
counting was performed by a squared grid and the density for each
patient was expressed as SICC number/Stissue area (mm2) found
in the 3 serial sections (20 fields/section). For each patient at least
20 mm2 (10 mm2 for CM and 10 for LM) were examined. For
each group (controls and DD patients), the density of ICC was
expressed as mean 6 SD of ICC density estimated in controls or
patients.
Statistical analysis
Statistical analysis was carried out using the Statistical Package
for Social Sciences software (SPSS version 17.0). Mann-Whitney
U-test for unpaired data was used to assess the statistical
differences between groups; p values ,0.05 were considered to
be significant.
Results
Histopathologic analysis, carried out by conventional haema-
toxylin and eosin staining, revealed a normal morphology, without
leukocyte infiltrate, in all sections of colonic samples from control
subjects and DD patients. However, some specimens from DD
patients showed a trend toward an increased thickness of the
smooth muscle layer. All markers under study were found to be
Table 1. Primary antibodies used in this study.
Antibody Species Source Dilution
Anti-human Cx43 Mouse monoclonal Santa Cruz Biotechnology, Santa Cruz, CA, USA 1:4500
Anti-human phospho-Cx43 (pS368-Cx43) Rabbit polyclonal Cell Signaling Technology, Beverly, MA, USA 1:50
Anti-human Cx26 Rabbit polyclonal Santa Cruz Biotechnology 1:200
Anti-human RhoA Rabbit polyclonal Santa Cruz Biotechnology 1:2500
Anti-phospho-PKC substrate (PKCps) Rabbit polyclonal Cell Signaling Technology 1:800
Anti-c-kit (CD117) Rabbit polyclonal DakoCytomation,Glostrup, Denmark 1:200
Anti-smooth muscle a-actin (1A4) Mouse monoclonal Cell Marque, Rocklin, CA, USA undiluted
doi:10.1371/journal.pone.0057023.t001
Figure 1. Positive control tissues for immunohistochemistry. (A,B) The crypts of normal human colon were selected as control positive
structures for Cx26 (A) and Cx43 (B): immunoreactivity is evident in the ephitelial cells of crypts (arrows). (C) Human myocardium was used as positive
control for pS368-Cx43: immunoreactivity is localized at level of intercalated disks (arrows); immunoreactivity of myocardium for Cx43 is displayed in
the box. (D) A human myenteric neuron, taken as a positive control cell for PKC, displays an intense PKCps immunoreaction. (E) A granulocyte of
normal colon, chosen as positive control for RhoA, is markedly immunoreactive. (F) Mast cells (arrows), locked in the tunica muscularis of human
normal colon, show a strong immunoreaction for c-Kit. In the same field an intramuscular c-Kit positive ICC is also evident (arrowhead). Scale bar:
50 mm.
doi:10.1371/journal.pone.0057023.g001
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expressed in the respective positive control tissues (Fig. 1), and they
were not detected in negative controls.
Expression of Cxs
Appreciable amounts of Cx26 and Cx43 immunostaining were
detected in SMCs of the tunica muscularis of all colonic specimens.
Normal colonic samples displayed a marked staining for both Cx
isoforms in the CM and LM layers, although the immunoreaction
products were mainly appreciable at level of the CM (Fig. 2A and
Fig. 3A). A spotted immunoreactivity was evident by high
magnification within SMCs, being mostly localized at the
membrane level. Specific immunostaining was also appreciable
at cytoplasmic and, for Cx43 in particular, at paranuclear and
nuclear level in a variety of cells (Fig. 2C,E and Fig. 3C,E).
In DD colonic samples, these patterns were markedly altered:
Cx26 and Cx43 positivity were reduced or focally lost in both CM
and LM layers of all pathological samples (Fig. 2B and Fig. 3B).
With regard for the pattern of cellular Cx distribution, there were
not remarkable variations, with exception for the paranuclear
localization, which appeared to be very faint (Fig. 2D,F and
Fig. 3D,F). This reduction was confirmed by quantitative analysis,
which highlighted a significantly lower percentage of Cx
immunostained areas in colonic DD samples, as compared to
controls (Fig. 2G, Fig. 3G).
No appreciable immunoreactivity for pS368-Cx43 was detected
in SMC of the tunica muscularis in both controls and DD samples
(Fig. 4). Nevertheless, the validity of immunostaining procedure
was testified by the marked pS368-Cx43 positivity detected at level
of intercalated disks of the myocardium, which is regarded as a
reliable positive control tissue for this antigen [13,20] (Fig. 1).
Expression of molecular factors involved in the
contractile function of SMCs
The activity of PKC was studied by detecting the levels of
phosphorylated PKC substrates. A diffuse, marked PKCps
immunostaining was observed in SMCs of all normal colonic
samples at level of the tunica muscularis. By contrast, a significant
decrease in PCKps immunostaining was found in DD samples
(Fig. 5A,B), as confirmed by quantitative analysis (Fig. 5C).
With regard for RhoA, two patterns of immunostaining could
be appreciated: 1) a cytoplasmic staining, corresponding to
inactivated GDP-bound RhoA, and 2) a plasma membrane
staining, corresponding to activated GTP-bound RhoA [23,25–
26]. A dotted, strong RhoA immunolabelling, distributed at level
of both cytoplasm and plasma membrane, was evident in SMCs of
the tunica muscularis in normal colon (Fig. 6A,C,E). By contrast, the
SMCs of DD colonic samples displayed a weak RhoA immuno-
reactivity, which was mostly localized in the cytoplasm
(Fig. 6B,D,F). Quantitative analysis confirmed the decreased
RhoA expression in colonic DD sections, as shown by the
significant differences between the PPP means of these two groups
(Fig. 6G).
a-SMA immunoreactivity labelled all the components of smooth
muscle layers including the SMCs of tunica muscularis. No
appreciable differences in the distribution patterns or the
quantitative expression of a-SMA were observed in the neuro-
muscular compartment when comparing DD colonic specimens
with normal colon (Fig. 7).
c-Kit positive ICCs
ICCs were identified by black c-Kit immunostaining and red
nuclei (Fig. 8). Strongly c-Kit immunostained cells, with morpho-
Figure 2. Cx26 immunostaining and quantitative analysis in the neuromuscular compartment of normal and diverticular disease
human colon. In normal colon, Cx26 is widely expressed in both circular (CM) and longitudinal muscle (LM) (A), while it is decreased in samples from
DD colon (B); scale bar: 100 mm. At higher magnification (C–F), SMCs show a punctuated immunoreactivity, which is localized at the membrane
(arrows), cytoplasmic (asterisks), paranuclear and nuclear (arrowheads) levels; scale bars: 50 mm. (G) Image analysis of Cx26 expression. Each column
represents the PPP mean 6 SD (9,n,11). *P,.05, significant difference vs normal colon.
doi:10.1371/journal.pone.0057023.g002
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logical appearance and size of mast cells, were excluded from the
analysis and were taken as internal positive controls (Fig. 1).
Normal colonic samples from control subjects displayed an
abundant presence of c-Kit-positive dendritic cells, widely spread
throughout the tunica muscularis, with their long processes running
along the major axis of SMCs. As compared to normal controls,
colonic specimens from DD patients showed considerable
alterations of the intramuscular ICC appearance and distribution
pattern. In particular, the c-Kit network was rarefied and
disarranged as a result of: 1) significant morphological alterations
of ICCs, which showed curtailed and blunted processes
(Fig. 8B,D,F); 2) decrease in ICC density in both CM and LM
(Fig. 8G).
Discussion
Intestinal motility is ensured by coordinated contractions of the
tunica muscularis, which depend from finely tuned interactions
among the myenteric motor neurons, enteric glial cells, ICCs and
SMCs of the CM and LM layers. Not all the intestinal SMCs are
individually innervated by enteric nerves and, for this reason, their
plasma membranes are equipped with a number of gap junctions,
built up by a complex coaxial arrangement of transmembrane
channels. These intercellular junctions allow the transmission of
signaling molecules from innervated SMCs to non-innervated
neighboring SMCs, thus orchestrating a coordinated motor
activity and the implementation of different bowel motor
programs. Among the molecular mechanisms which control the
morphology and functions of SMC gap junctions, it is being
increasingly appreciated that their permeability is regulated by
both RhoA monomeric GTPase, an emerging key regulator of
SMC phenotype [14], and PKC [13,27]. Interestingly, RhoA and
PKC are also involved in the control of SMC contraction [17].
To date, histopatological studies conducted on gastrointestinal
neuromuscular disorders have been mainly focused on the enteric
nervous system and ICCs, which have been found to be both
variously affected under different pathological conditions. By
contrast, although SMCs are well recognized as the final effectors
of enteric neuromuscular units and extensive electrophysiological
studies on SMCs have investigated the area of colonic motor
dysfunctions [28], scarce attention has been paid to the molecular
abnormalities of enteric musculature in gut dysmotility [29–32],
and data on SMCs in DD are lacking. Thus, we evaluated the
expression patterns of molecular factors involved in the contractile
functions of SMCs in colonic specimens from patients with DD. In
particular, we examined the expression of Cx26 and Cx43, which
are prominent components of gap junctions in human colonic
SMCs [11], and an array of signaling factors, which are known to
regulate both the functions of gap junctions and the contractile
activity of SMCs. Furthermore, due to the important role that
ICCs play in the electrical activity of SMCs, we deemed interesting
to evaluate also the distribution and density of ICCs in the tunica
muscularis of DD patients.
In the present study, all normal and DD colonic specimens,
examined by haematoxylin-eosin staining, displayed normal
morphological patterns, without significant evident histopatholog-
ical abnormalities in the neuromuscular compartment. Despite
Figure 3. Cx43 immunostaining and quantitative analysis in the neuromuscular compartment of normal and diverticular disease
human colon. In normal colon, appreciable amounts of Cx43 are expressed in the circular (CM) and longitudinal muscle (LM) (A), while Cx43
expression is decreased in samples from DD colon (B); scale bar: 100 mm. At higher magnification (C–F), SMCs show a punctuated immunoreactivity,
which is localized at the membrane (arrows), cytoplasmic (asterisks), paranuclear and nuclear (arrowheads) level; scale bars: 50 mm. (G) Image analysis
of Cx43 expression. Each column represents the PPP mean 6 SD (8,n,10). *P,.05, significant difference vs normal colon.
doi:10.1371/journal.pone.0057023.g003
Figure 4. Cx43 phosphorylated at serine 368 (pS368-Cx43)
immunostaining. No immunoreactivity is evident in the tunica
muscularis of normal (A) and DD (B) human colon; scale bar: 100 mm.
(C–D).
doi:10.1371/journal.pone.0057023.g004
Smooth Muscle Molecules in Diverticular Disease
PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57023
this finding, the immunohistochemical analysis revealed significant
abnormalities in DD samples, concerning both the expression and
distribution patterns of most of the investigated molecular factors.
Indeed, with exclusion of a-SMA and pS368-Cx43, whose
expressions were found to be similar in DD and normal samples,
all the remaining factors (Cx26, Cx43, PKCps and RhoA) were
markedly reduced.
Immunolabelling for Cx26 and Cx43 was positive, with
different degrees of expression, at level of the tunica muscularis in
the SMCs of normal and DD colonic specimens, both in CM and
LM layers. Of note, these Cx isoforms were not detected in LM of
the normal human colon in previous investigations [11]. However,
different immunostaining conditions might account for this
discrepancy. Indeed, when our experiments were repeated in
accordance with the procedure described by Kanczuga-Koda et
al. [11], Cx26 and Cx43 immunolabelling could not be visualized
in the LM of cross-sectioned colonic samples (data not shown).
This circumstance emphasizes the concept that comparable
Figure 5. PKC phosphorylated substrates immunostaining and quantitative analysis in the neuromuscular compartment of normal
and diverticular disease human colon. In normal colon, PKCps immunostaining is expressed in both circular (CM) and longitudinal muscle (LM)
(A), while it is reduced in DD (B); scale bars: 100 mm. Myenteric neurons (arrows) are intensely immunostained. (C) Image analysis of PKCps expression.
Each column represents the PPP mean 6 SD (9,n,11). **P,.005 and *P,.05, significant differences vs normal colon.
doi:10.1371/journal.pone.0057023.g005
Figure 6. RhoA immunostaining and quantitative expression in the neuromuscular compartment of normal and diverticular
disease human colon. In normal colon, RhoA is expressed in the circular (CM) and longitudinal muscle (LM) (A), while it is reduced in DD (B); scale
bar: 100 mm. At higher magnification, SMCs show a dotted immunoreactivity localized at the membrane (arrows) and cytoplasmic (asterisks) level in
normal colon (C,E), while in DD samples the localization is mainly evident in the cytoplasm (asterisks) (D,F); scale bars: 50 mm. (G) Image analysis of
RhoA expression. Each column represents the PPP mean 6 SD (9,n,11). **P,.005 and *P,.05, significant differences vs normal colon.
doi:10.1371/journal.pone.0057023.g006
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morphological examinations can be obtained only by a very close
adherence to standardized and validated procedures, which have
been largely advocated, particularly in the field of gastrointestinal
neuromuscular diseases [33–35].
Based on the role traditionally ascribed to gap junction
channels, the dramatic reduction of Cx expression found in DD
samples, at all cellular levels, could represent a correlate of
impaired junctional communications among adjacent SMCs.
However, besides the role played by Cxs in setting up gap
junctions, recent studies have demonstrated that hemichannels,
expressed at level of unopposed SMC membranes, can function
independently of cell-to-cell communication and can mediate the
exchange of small molecules between cells and the extracellular
environment [36]. In addition, membrane Cx43 regulates
intracellular signaling, acting as a scaffold which fosters protein–
protein interactions through the domains located in its cytoplasmic
C-terminus tail [36–38]. Furthermore, it has been shown that
intracellular Cxs may play a role as signal transduction molecules
involved in the modulation of cell proliferation and tumour
progression, as previously observed in human cancer cell lines
[39], as well as in human gastrointestinal tumours [40–41]. Thus,
in keeping with current knowledge, the membrane localization of
Cx proteins, as detected in our study, might reflect their presence
in the structure of gap junctions or their function as scaffold
proteins involved in signal transduction. On the other hand, the
cytoplasmic and paranuclear localizations of Cxs might be
associated with molecule trafficking towards or from SMC plasma
membranes, during the process of setting up or disassembling gap
junctions, as well as with signal proteins translocating to the
nucleus. In this respect, the decrease in Cx expression, as observed
in our DD samples, could explain the concomitant decrease in
RhoA and PKCps expression, since Cxs might be also involved in
the control of these signaling pathways.
Previous evidence supports the view that Cx phosphorylation
has relevant modulating actions on gap junction activity.
Therefore, we examined the expression of pS368-Cx43, which
has been recently demonstrated to reduce the conductance of gap
junction channels in both myocardiocytes [13] and vascular SMCs
[42]. Since in all our specimens, from either normal or DD colon,
the expression of pS368-Cx43 could not be detected, despite its
presence in positive control tissues, it can be argued that this
molecular mechanism may not be involved in the control of gap
junction permeability at level of human colonic SMCs. However,
other molecular sites of Cx43 phosphorylation, differing from
Ser368, or other phosphorylated Cx isoforms, might be involved
Figure 7. Smooth muscle a-actin (a-SMA) immunostaining. a-
SMA is equally expressed in circular (CM) and longitudinal muscle (LM)
of normal (A) and diverticular disease (DD) (B) human colon. Scale bar:
100 mm.
doi:10.1371/journal.pone.0057023.g007
Figure 8. Immunostaining and quantitative analysis of ICCs in neuromuscular compartment of normal and diverticular disease
human colon. Colonic specimens from DD patients contain fewer c-Kit positive and nuclear fast red-counterstained ICCs, with blunted and
shortened branching (B, D, F), as compared to normal colon. Scale bars: 100 mm (A, B) and 50 mm (C–F). (G) Column graphs display ICC counting
which is given as means 6 SD of individual ICC densities normalized to area for ICC-CM (C) and ICC-LM (I).*P,.05,significant difference vs normal
colon.
doi:10.1371/journal.pone.0057023.g008
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in the regulation of channel permeability, and these possibilities
deserve careful consideration in future studies.
With regard for the molecular factors known to regulate the
permeability of Cx43-based channels, the activation of PKC and
RhoA has been considered in the present study. Indeed, as
anticipated above, PKC can induce the reduction of gap junction
conductance by direct phosphorylation of Cx43 at serine 368 in
myocardial tissue [13]. By contrast, RhoA activation has been
reported to enhance the processes of cell-to-cell solute diffusion,
without modifying the cellular redistribution of junctional plaques
or the Cx43 phosphorylation pattern in myocardiocyte plasma
membranes [14]. Furthermore, RhoA/ROCK and PKC/CPI-17
have been found to represent the relevant molecular pathways
controlling the contractility of gastrointestinal SMCs. In particu-
lar, PKC and RhoA signaling can positively influence the late
phase of contraction, acting by two parallel signal pathways, which
ultimately lead to the inhibition of myosin light chain phosphatase,
with a consequent enhancement of tonic SMC contractile activity.
It is also interesting to note that different roles can be played by
RhoA and PKC pathways depending on the anatomical region at
which the motor activity is considered [17]. When referring our
results to this background knowledge, the significant decrease in
RhoA expression, and activity in DD colonic SMCs, as suggested
by its reduced plasma membrane content, could reflect an
impairment of intercellular communications among SMCs. By
contrast, when considering the decrease in PKC activity, as
demonstrated by the reduction of PKC phosphorylated substrate
expression, this pathway does not appear to be involved in the
control of intercellular communication by Cx43 phosphorylation
at Ser368. This view is supported by our observation showing that
the appreciable amount of PKC substrates, detected in normal
colon, were not associated with the expression pattern of
immunolabelled pS368-Cx43. As an alternative explanation, the
reduced RhoA and PKCps immunostaining in DD colon might be
representative of an altered condition of intracellular signaling
regulating SMC contraction. In particular, the altered phenotype
observed in SMCs of DD samples could be compatible with an
inhibition of the RhoA/ROCK pathway. Interestingly, such a
condition, which might lead to loosening of colonic tunica muscularis
in DD patients, has been shown to directly affect the relaxation of
SMCs [17]. Overall, in predisposed individuals these changes
might facilitate a collapse and/or weakening of tensile strength in
the tunica muscularis, with a consequent risk of forming diverticula
by herniation of the colonic wall, especially in the sigmoid colon,
where the pressures toward the wall are greater, and even under
normal physiological conditions there is a continuous motor
activity acting as a physiological brake on the colonic content [43–
44].
Within a framework of SMC failure, characterized by a
significant decrease in the expression/activity of molecular factors
involved in the control of SMC contractility, the role played by
ICCs in the modulation of enteric neuromuscular transmission
deserves a careful consideration. These cells function primarily as
pacemakers, but they can also act as cellular bridges connecting
nerve varicosities with several SMCs, thus ensuring a proper
diffusion of contractile inputs throughout the tunica muscularis [45].
In this respect, the analysis of neuromuscular ICC density, as
performed in the present study, highlighted a significant decrease
in the density of these cells throughout the whole tunica muscularis of
DD patients, at level of both CM and LM layers, in agreement
with previous results reported by Bassotti et al. [7]. Of note,
patients with DD have been shown to display an increase in both
overall and rhythmic colonic contractions [2,46]. Since studies on
rat [47] and human [48] colonic muscle have suggested that ICCs
are likely to inhibit colonic motility by nitric oxide release, the
reduction of intramuscular ICC, as observed in the colon of DD
patients, might result in an increment of SMC contractility, as
repeteadly observed in these patients [4].
In conclusion, the present results provide the first evidence of
altered expression patterns of important molecular factors involved
in the regulation of SMC contractility at level of the tunica
muscularis of DD patients. Considering that our analysis was
conducted on colonic tissues, which were taken from DD patients
but were not directly affected by diverticular lesions or inflamma-
tory reactions, it is conceivable that these molecular alterations, as
highlighted by the present immunohistochemical assay, may
precede and predispose to the formation of diverticula, rather
than being mere consequences of the disease.
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